2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one(2Z)-2-butenedioate 马来酸阿洛司琼
CAS 122852-43-1 MFCD22852431
化学结构图
SMILES:
化学属性
| Mol. Formula | C17H18N4O.C4H4O4 |
|---|
别名和识别编码
| Chemical Name | 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one(2Z)-2-butenedioate |
|---|---|
| Chemical Name Translation | 马来酸阿洛司琼 |
| Chemicalbook ID | CB82614319 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Lucak SL.
- [3]. Lewis JH.
- [4]. Painsipp E, Shahbazian A, Holzer P.
- [5]. Targeting the 5-HT3 receptor in the treatment of irritable bowel syndrome By Spiller, Robin C.From Current Opinion in Pharmacology (2011), 11(1), 68-74.
- Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
- Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
- Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
- Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
- Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.
- Alosetron, cilansetron and tegaserod modify mesenteric but not colonic blood flow in rats.
- Br J Pharmacol. 2009 Nov;158(5):1210-26.
- Br J Pharmacol. 2009 Nov;158(5):1210-26.
- Cu
